Roussy-Lévy disease
Roussy-Lévy Syndrome is a genetic disorder characterized by a combination of peripheral neuropathy, muscle weakness, and tremors. It is a type of Charcot-Marie-Tooth disease (CMT), specifically classified as CMT type 1. This condition is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene is necessary for the disorder to be passed down from parents to their children.
Symptoms and Diagnosis[edit | edit source]
The primary symptoms of Roussy-Lévy Syndrome include muscle weakness and atrophy, particularly in the lower legs, leading to difficulties in walking and frequent tripping or falls. Affected individuals may also experience a significant tremor in their hands, complicating tasks that require fine motor skills. Diagnosis is typically based on clinical examination, family history, and may be confirmed through genetic testing. Electromyography (EMG) and nerve conduction studies can also aid in the diagnosis by demonstrating characteristic patterns of nerve damage.
Genetics[edit | edit source]
Roussy-Lévy Syndrome is caused by mutations in the same genes responsible for certain forms of Charcot-Marie-Tooth disease, most commonly the PMP22, MPZ, or MFN2 genes. These genes are involved in the structure and function of peripheral nerves. Mutations in these genes disrupt the normal function of the nerves, leading to the symptoms observed in the syndrome.
Treatment and Management[edit | edit source]
There is currently no cure for Roussy-Lévy Syndrome. Treatment focuses on managing symptoms and improving quality of life. Physical therapy and occupational therapy can help maintain muscle strength and improve coordination. Orthopedic devices, such as braces or orthotic shoes, may be recommended to assist with walking and mobility. In some cases, pain relief medication may be prescribed to manage discomfort associated with nerve damage.
Prognosis[edit | edit source]
The prognosis for individuals with Roussy-Lévy Syndrome varies. While the condition is typically slowly progressive, most affected individuals live a normal lifespan. The severity of symptoms can vary widely, even among members of the same family. Early intervention and supportive care can help manage symptoms and maintain mobility.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD